HU222501B1
(hu)
*
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
ZA924811B
(en)
*
|
1991-06-28 |
1993-12-29 |
Endorecherche Inc |
Controlled release systems and low dose androgens
|
US20020091155A1
(en)
*
|
1995-06-22 |
2002-07-11 |
Btg Pharmaceutical Corp. |
Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
|
AU5855794A
(en)
*
|
1993-01-19 |
1994-08-15 |
Endorecherche Inc. |
Therapeutic uses and delivery systems of dehydroepiandrosterone
|
US5776923A
(en)
*
|
1993-01-19 |
1998-07-07 |
Endorecherche, Inc. |
Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
|
US6407082B1
(en)
*
|
1996-09-13 |
2002-06-18 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a vitamin D compound
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US5574011A
(en)
*
|
1995-04-04 |
1996-11-12 |
Tien; Henry C. |
Compositions and methods for the treatment of male-pattern baldness
|
US5910492A
(en)
*
|
1995-06-05 |
1999-06-08 |
Takeda Chemical Industries, Ltd. |
Osteogenic promoting pharmaceutical composition
|
WO1997004752A1
(en)
*
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
US6511970B1
(en)
|
1996-09-13 |
2003-01-28 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
|
US6028064A
(en)
|
1996-09-13 |
2000-02-22 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of progestin products
|
US6765002B2
(en)
|
2000-03-21 |
2004-07-20 |
Gustavo Rodriguez |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
|
US6034074A
(en)
|
1996-09-13 |
2000-03-07 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a Vitamin D compound
|
US6576659B1
(en)
*
|
1996-12-05 |
2003-06-10 |
Bio-Technology General Corp. |
Use of oxandrolone in the treatment of burns an other wounds
|
US5855920A
(en)
*
|
1996-12-13 |
1999-01-05 |
Chein; Edmund Y. M. |
Total hormone replacement therapy
|
US6416778B1
(en)
|
1997-01-24 |
2002-07-09 |
Femmepharma |
Pharmaceutical preparations and methods for their regional administration
|
US6028057A
(en)
*
|
1998-02-19 |
2000-02-22 |
Thorn Bioscience, Llc |
Regulation of estrus and ovulation in gilts
|
BR9908592A
(pt)
*
|
1998-03-11 |
2001-04-24 |
Endorech Inc |
Processo para inibir a atividade de 17ß-hidroxiesteróide desidrogenase tipo 5, composição farmacêutica, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 5, processo para inibir 17ß-hidroxiesteróide desidrogenase tipo 3, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 3, processos para tratar, ou reduzir o risco de desenvolver, câncer da próstata, hiperplasia prostática benigna, acne, seborréia, hirsutismo ou alopécia androgênica, sìndrome de ovário policìstico, câncer de mama, endometriose ou leiomioma, para inibir as secreções hormonais testiculares, para tratar puberdade precoce, e, kit
|
KR100293504B1
(ko)
|
1998-06-05 |
2001-07-12 |
김윤 |
서방형전립선염치료제조성물
|
US7005428B1
(en)
|
1998-06-11 |
2006-02-28 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
US6294188B1
(en)
|
1998-07-09 |
2001-09-25 |
Aviana Biopharm Inc. |
Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
|
AU4957999A
(en)
*
|
1998-07-17 |
2000-02-07 |
Pharmacia & Upjohn Company |
Subcutaneous medroxyprogesterone acetate for contraception
|
JP2002527380A
(ja)
*
|
1998-10-09 |
2002-08-27 |
ファルマシア・アンド・アップジョン・カンパニー |
閉経および子宮内膜症の治療用の皮下酢酸メドロキシプロゲステロン
|
US6194006B1
(en)
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
US6498153B1
(en)
|
1998-12-31 |
2002-12-24 |
Akzo Nobel N.V. |
Extended release growth promoting two component composition
|
US7018654B2
(en)
*
|
1999-03-05 |
2006-03-28 |
New River Pharmaceuticals Inc. |
Pharmaceutical composition containing an active agent in an amino acid copolymer structure
|
US6716452B1
(en)
|
2000-08-22 |
2004-04-06 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US6613758B1
(en)
|
1999-04-02 |
2003-09-02 |
Barr Laboratories, Inc. |
Method for treating osteoporosis in castrated prostatic cancer patients
|
WO2000062759A1
(en)
*
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
DK1175433T3
(da)
|
1999-05-04 |
2005-09-19 |
Strakan Int Ltd |
Androgenglycosider og androgen aktivitet deraf
|
US6187750B1
(en)
|
1999-08-25 |
2001-02-13 |
Everyoung Technologies, Inc. |
Method of hormone treatment for patients with symptoms consistent with multiple sclerosis
|
US6846496B1
(en)
|
1999-10-15 |
2005-01-25 |
Orion Corporation |
Treatment of osteoporosis
|
US6331317B1
(en)
|
1999-11-12 |
2001-12-18 |
Alkermes Controlled Therapeutics Ii Inc. |
Apparatus and method for preparing microparticles
|
US6495166B1
(en)
|
1999-11-12 |
2002-12-17 |
Alkermes Controlled Therapeutics Inc. |
Apparatus and method for preparing microparticles using in-line solvent extraction
|
US6705757B2
(en)
*
|
1999-11-12 |
2004-03-16 |
Alkermes Controlled Therapeutics, Inc. Ii |
Method and apparatus for preparing microparticles using in-line solvent extraction
|
US6682754B2
(en)
*
|
1999-11-24 |
2004-01-27 |
Willmar Poultry Company, Inc. |
Ovo delivery of an immunogen containing implant
|
AP2002002552A0
(en)
|
1999-12-23 |
2002-06-30 |
Pfizer Prod Inc |
Pharmaceutical compositions providing enhanced drug concentrations.
|
US6562790B2
(en)
|
2000-02-05 |
2003-05-13 |
Chein Edmund Y M |
Hormone therapy methods and hormone products for abating coronary artery blockage
|
AU2001241779A1
(en)
|
2000-02-25 |
2001-09-03 |
Hollis-Eden Pharmaceuticals, Inc. |
Method of treatment of prostate cancer
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US7989436B2
(en)
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US6660726B2
(en)
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US20010044431A1
(en)
*
|
2000-03-21 |
2001-11-22 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
US7018645B1
(en)
*
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
FR2811218B1
(fr)
|
2000-07-05 |
2003-02-28 |
Patrice Suslian |
Dispositif implantable destine a corriger l'incontinence urinaire
|
DE60127139T2
(de)
*
|
2000-07-14 |
2007-12-13 |
Novo Nordisk A/S |
Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
CA2453050A1
(en)
*
|
2000-09-06 |
2002-03-14 |
A.P. Pharma, Inc. |
Degradable polyacetal polymers
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6471995B1
(en)
*
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
US20060205995A1
(en)
*
|
2000-10-12 |
2006-09-14 |
Gyne Ideas Limited |
Apparatus and method for treating female urinary incontinence
|
GB0025068D0
(en)
*
|
2000-10-12 |
2000-11-29 |
Browning Healthcare Ltd |
Apparatus and method for treating female urinary incontinence
|
US8167785B2
(en)
|
2000-10-12 |
2012-05-01 |
Coloplast A/S |
Urethral support system
|
US8394813B2
(en)
|
2000-11-14 |
2013-03-12 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
GB0108088D0
(en)
*
|
2001-03-30 |
2001-05-23 |
Browning Healthcare Ltd |
Surgical implant
|
US7169752B2
(en)
*
|
2003-09-30 |
2007-01-30 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US20060014697A1
(en)
*
|
2001-08-22 |
2006-01-19 |
Travis Mickle |
Pharmaceutical compositions for prevention of overdose or abuse
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
AU2002366800B2
(en)
|
2001-12-20 |
2006-08-03 |
Femmepharma Holding Company, Inc. |
Vaginal delivery of drugs
|
JP2005519964A
(ja)
*
|
2002-03-11 |
2005-07-07 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
スルファターゼ阻害プロゲストゲンのみの避妊レジメン
|
EP1492459A2
(de)
*
|
2002-04-11 |
2005-01-05 |
Gyne Ideas Limited |
Vorrichtung und verfahren zur behandlung von weiblicher urinärer inkontinenz
|
EP1829529A1
(de)
*
|
2002-05-03 |
2007-09-05 |
PR Pharmaceuticals, Inc. |
Zusammensetzungen zur kontrollierten Freisetzung von Estradiolmetaboliten
|
EP1507514B1
(de)
*
|
2002-05-03 |
2007-02-14 |
PR Pharmaceuticals, Inc. |
Zusammensetzungen aus östradiol-metaboliten mit kontrollierter freisetzung
|
DE60334919D1
(de)
|
2002-08-02 |
2010-12-23 |
Bard Inc C R |
Selbstverankerndes schlingen- und einführsystem
|
MXPA05007266A
(es)
*
|
2003-01-02 |
2006-01-17 |
Femmepharma Holding Co Inc |
Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
GB0307082D0
(en)
|
2003-03-27 |
2003-04-30 |
Gyne Ideas Ltd |
Drug delivery device and method
|
US6992075B2
(en)
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
MXPA05010871A
(es)
*
|
2003-04-11 |
2005-11-25 |
Barr Lab Inc |
Metodos para administrar estrogenos y progestinas.
|
US7056591B1
(en)
|
2003-07-30 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same
|
JP5651279B2
(ja)
|
2003-09-03 |
2015-01-07 |
ミスコン トレイディング エス.エー. |
子宮内膜症の処置のための方法
|
ES2555681T3
(es)
*
|
2003-10-03 |
2016-01-07 |
Thorn Bioscience, Llc |
Procedimiento para la sincronización de la ovulación para la fecundación programada sin detección del celo
|
US9114198B2
(en)
*
|
2003-11-19 |
2015-08-25 |
Advanced Cardiovascular Systems, Inc. |
Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
|
US7220816B2
(en)
*
|
2003-12-16 |
2007-05-22 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same
|
US7435788B2
(en)
*
|
2003-12-19 |
2008-10-14 |
Advanced Cardiovascular Systems, Inc. |
Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
|
WO2005068020A1
(en)
*
|
2004-01-02 |
2005-07-28 |
Advanced Cardiovascular Systems, Inc. |
High-density lipoprotein coated medical devices
|
US8685431B2
(en)
*
|
2004-03-16 |
2014-04-01 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
|
US8778014B1
(en)
|
2004-03-31 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for preventing balloon damage to polymer coated stents
|
WO2005110425A1
(en)
|
2004-04-15 |
2005-11-24 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US7334330B2
(en)
*
|
2004-04-28 |
2008-02-26 |
Siemens Power Generation, Inc. |
Thermally insulating layer incorporating a distinguishing agent and method for inspecting the same
|
US20050288481A1
(en)
*
|
2004-04-30 |
2005-12-29 |
Desnoyer Jessica R |
Design of poly(ester amides) for the control of agent-release from polymeric compositions
|
US7820732B2
(en)
*
|
2004-04-30 |
2010-10-26 |
Advanced Cardiovascular Systems, Inc. |
Methods for modulating thermal and mechanical properties of coatings on implantable devices
|
GB0411360D0
(en)
|
2004-05-21 |
2004-06-23 |
Mpathy Medical Devices Ltd |
Implant
|
US20050271700A1
(en)
*
|
2004-06-03 |
2005-12-08 |
Desnoyer Jessica R |
Poly(ester amide) coating composition for implantable devices
|
US20050287184A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Hossainy Syed F A |
Drug-delivery stent formulations for restenosis and vulnerable plaque
|
US7311980B1
(en)
|
2004-08-02 |
2007-12-25 |
Advanced Cardiovascular Systems, Inc. |
Polyactive/polylactic acid coatings for an implantable device
|
PT1781264E
(pt)
|
2004-08-04 |
2013-10-16 |
Evonik Corp |
Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
|
US7166680B2
(en)
*
|
2004-10-06 |
2007-01-23 |
Advanced Cardiovascular Systems, Inc. |
Blends of poly(ester amide) polymers
|
US8835413B2
(en)
|
2004-10-20 |
2014-09-16 |
Endorecherche, Inc. |
Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
|
US8603634B2
(en)
|
2004-10-27 |
2013-12-10 |
Abbott Cardiovascular Systems Inc. |
End-capped poly(ester amide) copolymers
|
US20060089485A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Desnoyer Jessica R |
End-capped poly(ester amide) copolymers
|
US7390497B2
(en)
*
|
2004-10-29 |
2008-06-24 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) filler blends for modulation of coating properties
|
US8609123B2
(en)
*
|
2004-11-29 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Derivatized poly(ester amide) as a biobeneficial coating
|
US7419504B2
(en)
*
|
2004-12-27 |
2008-09-02 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) block copolymers
|
US8007775B2
(en)
*
|
2004-12-30 |
2011-08-30 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
|
US8128952B2
(en)
*
|
2005-01-12 |
2012-03-06 |
Clemson University Research Foundation |
Ligand-mediated controlled drug delivery
|
US7202325B2
(en)
|
2005-01-14 |
2007-04-10 |
Advanced Cardiovascular Systems, Inc. |
Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles
|
CA2601773A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Compositions of unconjugated estrogens and methods for their use
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
EP1848410A4
(de)
*
|
2005-02-17 |
2011-11-09 |
Medivas Llc |
Zusammensetzungen zur ausgabe von polymerteilchen und anwendungsverfahren dafür
|
US20070020312A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Desnoyer Jessica R |
Method of fabricating a bioactive agent-releasing implantable medical device
|
US8377462B2
(en)
*
|
2005-07-29 |
2013-02-19 |
Advanced Cardiovascular Systems, Inc. |
PEA-TEMPO/PEA-BZ coatings for controlled delivery of drug from implantable medical devices
|
CA2623239C
(en)
*
|
2005-09-22 |
2016-07-12 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
US8445007B2
(en)
|
2005-09-22 |
2013-05-21 |
Medivas, Llc |
Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
|
US20070077269A1
(en)
*
|
2005-10-04 |
2007-04-05 |
Woodward John R |
Method of birth control and hormone regulation
|
JP5449775B2
(ja)
|
2005-10-19 |
2014-03-19 |
チャバフ ピーティーワイ エルティーディー |
乳癌の治療に使用されるアロマターゼ阻害薬による副作用の低減
|
EP1962894A4
(de)
*
|
2005-12-07 |
2012-11-14 |
Medivas Llc |
Verfahren zum zusammensetzen einer polymer-zusammensetzung zur abgabe eines biologischen mittels
|
US20070135909A1
(en)
*
|
2005-12-08 |
2007-06-14 |
Desnoyer Jessica R |
Adhesion polymers to improve stent retention
|
US20070197435A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Webel Stephen K |
Process for the synchronization of ovulation for timed breeding without heat detection
|
US7910152B2
(en)
*
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
WO2007130477A2
(en)
*
|
2006-05-02 |
2007-11-15 |
Medivas, Llc |
Delivery of ophthalmologic agents to the exterior or interior of the eye
|
WO2007133616A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Medivas, Llc |
Biodegradable water soluble polymers
|
US8323676B2
(en)
*
|
2008-06-30 |
2012-12-04 |
Abbott Cardiovascular Systems Inc. |
Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
|
US20090258028A1
(en)
*
|
2006-06-05 |
2009-10-15 |
Abbott Cardiovascular Systems Inc. |
Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
|
US7771739B2
(en)
*
|
2006-06-30 |
2010-08-10 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices comprising semi-crystalline poly(ester-amide)
|
US9028859B2
(en)
*
|
2006-07-07 |
2015-05-12 |
Advanced Cardiovascular Systems, Inc. |
Phase-separated block copolymer coatings for implantable medical devices
|
US8030436B2
(en)
*
|
2006-07-13 |
2011-10-04 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester-amide) elastomers and their use with implantable medical devices
|
US20090181063A1
(en)
*
|
2006-07-13 |
2009-07-16 |
Michael Huy Ngo |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
US7731987B2
(en)
*
|
2006-07-13 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
US20080014245A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Stephen Pacetti |
Drug-eluting implantable medical device with free radical scavenger for protecting drugs during sterilization and related method
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
EP2104489A2
(de)
*
|
2006-12-26 |
2009-09-30 |
FemmePharma Holding Company, Inc. |
Topische verabreichung von danazol
|
US20080175882A1
(en)
*
|
2007-01-23 |
2008-07-24 |
Trollsas Mikael O |
Polymers of aliphatic thioester
|
EP2131815A4
(de)
*
|
2007-03-22 |
2012-11-07 |
Alkermes Inc |
Koazervierungsverfahren
|
MX2009011123A
(es)
|
2007-04-23 |
2009-11-02 |
Intarcia Therapeutics Inc |
Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
|
US8252361B2
(en)
*
|
2007-06-05 |
2012-08-28 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices for local and regional treatment
|
US20080306584A1
(en)
*
|
2007-06-05 |
2008-12-11 |
Pamela Kramer-Brown |
Implantable medical devices for local and regional treatment
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
US9737638B2
(en)
|
2007-06-20 |
2017-08-22 |
Abbott Cardiovascular Systems, Inc. |
Polyester amide copolymers having free carboxylic acid pendant groups
|
US7927621B2
(en)
*
|
2007-06-25 |
2011-04-19 |
Abbott Cardiovascular Systems Inc. |
Thioester-ester-amide copolymers
|
WO2009015143A1
(en)
*
|
2007-07-24 |
2009-01-29 |
Medivas, Llc |
Biodegradable cationic polymer gene transfer compositions and methods of use
|
US8268806B2
(en)
|
2007-08-10 |
2012-09-18 |
Endorecherche, Inc. |
Pharmaceutical compositions
|
JP5502751B2
(ja)
|
2007-12-20 |
2014-05-28 |
エボニック コーポレイション |
低残留溶媒濃度を有する微粒子を調製するためのプロセス
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
US8889172B1
(en)
|
2008-04-30 |
2014-11-18 |
Abbott Cardiovascular Systems Inc. |
Amorphous or semi-crystalline poly(ester amide) polymer with a high glass transition temperature
|
US8765162B2
(en)
*
|
2008-06-30 |
2014-07-01 |
Abbott Cardiovascular Systems Inc. |
Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
|
EP2323671A4
(de)
*
|
2008-08-13 |
2012-09-26 |
Medivas Llc |
Biologisch abbaubare aabb-poly(depsipeptid-)polymere sowie verfahren zu ihrer verwendung
|
US20100047319A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Michael Huy Ngo |
Biodegradable Poly(Ester-Amide) And Poly(Amide) Coatings For Implantable Medical Devices With Enhanced Bioabsorption Times
|
EP2398461A1
(de)
|
2009-02-18 |
2011-12-28 |
Bayer Pharma Aktiengesellschaft |
Formulierung mit drospirenon zur subkutanen oder intramuskulären verabreichung
|
US20120114757A1
(en)
|
2009-02-18 |
2012-05-10 |
Bayer Pharma Aktiengesellschaft |
Particles comprising drospirenone encapsulated in a polymer
|
DK2421545T3
(en)
|
2009-04-23 |
2018-03-12 |
Jbs United Animal Health Ii Llc |
PROCEDURE AND COMPOSITION TO SYNCHRONIZE THE TIME OF INSEMINATION.
|
US20110003000A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Femmepharma Holding Company, Inc. |
Transvaginal Delivery of Drugs
|
NZ598686A
(en)
|
2009-09-28 |
2014-05-30 |
Intarcia Therapeutics Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
CN103619910B
(zh)
|
2011-06-23 |
2016-08-31 |
帝斯曼知识产权资产管理有限公司 |
用于药物递送的新颖的聚酯酰胺共聚物
|
MX353280B
(es)
*
|
2012-06-27 |
2018-01-05 |
Medincell |
Suministro de farmaco biodegradable para las composiciones hidrofobicas.
|
CN104994865A
(zh)
|
2012-11-28 |
2015-10-21 |
杰碧斯联合动物健康第二有限责任公司 |
用于同步小母猪的授精时间的方法
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
CA2965372C
(en)
|
2014-10-22 |
2023-09-05 |
Havah Therapeutics Pty Ltd |
Methods of reducing mammographic breast density and/or breast cancer risk
|
WO2016097297A1
(en)
|
2014-12-18 |
2016-06-23 |
Dsm Ip Assets B.V. |
Drug delivery system for delivery of acid sensitive drugs
|
AU2016270984B2
(en)
|
2015-06-03 |
2021-02-25 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
EP3364978A4
(de)
|
2015-10-22 |
2019-06-05 |
Havah Therapeutics Pty Ltd |
Verfahren zur reduzierung der mammografischen brustdichte und/oder des brustkrebsrisikos
|
CA3004849A1
(en)
|
2015-11-16 |
2017-05-26 |
Georges Gaudriault |
A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
|
CN109310743A
(zh)
|
2016-05-16 |
2019-02-05 |
因塔西亚制药公司 |
胰高血糖素受体选择性多肽及其使用方法
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
EP3565580B1
(de)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Kontinuierlicher verabreichung von exenatid und co-verabreichung von acetaminophen, ethinylestradiol oder levonorgestrel
|
US11524014B2
(en)
|
2019-06-03 |
2022-12-13 |
Havah Therapeutics Pty Ltd. |
Pharmaceutical formulations and systems for delivery of an androgenic agent and an aromatase inhibitor with sustained multi-phasic release profiles and methods of use
|